British biotech firm Redx Pharma plc and U.S.-based Jounce Therapeutics Inc will merge to create a $425 million entity specialised in treating cancer and fibrotic disease. Redx shareholders will receive 0.2105 Jounce...
Sun Pharma acquires 26.09% stake in Agatsa Software, 27.39% in Remidio Innovative Solutions
Drug major Sun Pharma has announced that it has acquired a 26.09% stake in Agatsa Software Private Limited, which is in an early-stage digital diagnostic devices company, for ₹30 crore in two tranches. The acquisition...
Sun Pharma buys Disperzyme, Phlogam brands from Aksigen Hospital Care
Indian drug major Sun Pharmaceutical Industries said it has bought anti-inflammatory brands Disperzyme, Disperzyme-CD, and Phlogam from Mumbai-based Aksigen Hospital Care for an undisclosed amount. All three brands are...
Advent to buy into Suven Pharma to create manufacturing powerhouse
Advent International on Monday agreed to acquire 50.1% of Suven Pharmaceuticals Ltd from the Jasti family, promoters of the company, for ₹6,313 crore, as part of the private equity firm’s plan to create a contract drug...
Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 cr
Advent International is expected to sign a binding agreement to buy Suven Pharmaceuticals, a Hyderabad-based listed contract research and manufacturing services (CRAMS) company, as early as Monday morning, people...
JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore
JB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in an all-cash deal. The acquisition will be funded through long-term debt and...
Gland Pharma acquires French CDMO Cenexi for €120 million
Gland Pharma said that its Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development & manufacturing organisation (CDMO) Cenexi Group for...
Mankind Pharma acquires majority stake in Upakarma Ayurveda
Mankind Pharma said it has acquired a majority stake in Upakarma Ayurveda, engaged in developing, manufacturing and selling ayurvedic and herbal products for an undisclosed amount. The company’s decision to invest...
CCI clears Abu Dhabi Investment Authority’s minority stake buy in Intas Pharmaceuticals
Anti-trust regulator Competition Commission of India (CCI) cleared Platinum Owl’s acquisition of a minority stake in Intas Pharmaceuticals. The proposed transaction involves a secondary acquisition by Platinum Owl...
Myovant Sciences rejects $2.5 billion takeover bid from Sumitovant, Sumitomo Pharma
Myovant Sciences Ltd said it rejected a $2.5 billion takeover offer from Sumitovant Biopharma and its parent group Sumitomo Pharma Co Ltd as the bid “significantly undervalues” the U.S. drugmaker...
Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 crores
Ahmedabad-based Torrent Pharmaceuticals Limited has entered into a definitive agreement to acquire 100% of skincare manufacturer Curatio Healthcare for Rs. 2,000 crores. Skincare product maker- Curatio has a strong...
CCI clears deal involving Sekhmet Pharmaventures, Optimus Drugs
The Competition Commission of India approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd. Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs. The fair...